🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Could harnessing the body’s own #ImmuneSystem stop the progression of #OvarianCancer? Read more about Dr Zoe Marks, Prof Paul Hertzog, Dr Nicole Campbell (L-R) & the team's latest research in the prestigious journal nature or here bit.ly/3KJCFzY

Major congratulations to Paul Hertzog DrNicoleCampbell.bsky.social Zoe RC Marks Nollaig Bourke et al. on their publication of this CiiiD-led study on IFNε in #ovariancancer, out today in nature! Read more Hudson Institute of Medical Research⬇️

Thrilled to celebrate this milestone!

Nature research paper: Interferon-ε is a tumour suppressor expressed in the epithelial cell of origin of ovarian cancer, which it restricts by direct action on tumour cells and especially by activation of anti-tumour immunity. go.nature.com/459So3v

Testing people at risk of hepatitis C infection should be better integrated into opioid treatment programs if eradication is to be achieved by 2030. ow.ly/OZg750Pykvz #AusHealth #Healthcare #HepC

#WeekendRead! #InterferonPower! Paul Hertzog, Nollaig Bourke, DrNicoleCampbell.bsky.social &co show nature that #IFNepsilon act against #ovarian #cancer affecting directly tumor cells, or leading to T and NK cells activity, limiting MDSCs & Treg cells pro-tumor functions! Doi.org/10.1038/s41586…

Congratulations to CiiiD ECR DrNicoleCampbell.bsky.social on being awarded Runner Up for Best Talk at ImmuMon! 👏

Using modern biological tools, researchers engineered #cancer cells with and without specific chromosome abnormalities, showing how tumors rely on them for survival and clarifying the biological role of aneuploidy. Learn more this week in Science: scim.ag/3QC

Grateful to Science Signaling for the editors choice on our paper on IFNe in ovarian cancer pub in nature Nollaig Bourke Zoe RC Marks DrNicoleCampbell.bsky.social CiiiD Hudson Hudson Institute of Medical Research Monash University School of Clinical Sciences

Thank you Science Signaling for featuring our paper! Very grateful to be able to share the role of IFN epsilon in #ovariancancer DrNicoleCampbell.bsky.social Nollaig Bourke Paul Hertzog Hudson Institute of Medical Research

ANZGOG's EPOCH study has recruited its first patient at Peter Mac Cancer Centre 👏 EPOCH is a Phase II open label international clinical trial, which seeks to improve outcomes in women with tubo-ovarian or uterine carcinosarcoma by providing patients with access to a treatment that offers a

Thanks to Nature Rev Immunol & Yvonne Bordon for the feature! 😄

Thanks to Samar Elorbany, Beatrice Malacrida & Frances Balkwill Queen Mary University of London for the write up in Trends in Cancer! Cell Find it 👉 cell.com/trends/cancer/…

Interferon epsilon’s protection extends to the intestinal@micosa cmghjournal.org/cms/attachment…

Very exciting work by Nollaig Bourke Trinity College Dublin! Look forward to future discoveries in type I IFN and ageing

Our second plenary talk from Prof. Paul Hertzog Paul Hertzog at #lorneiandi 2024 has highlighted new and unexpected roles for interferon epsilon in cancer. A fantastic and engaging talk!

Tomorrow is March, the start of #OvarianCancerAwarenessMonth. That means it's our chance to put #ovariancancer in the spotlight! 🌟 Will you repost this to help us raise awareness of the symptoms of #ovariancancer?

Not your average Saturday morning! I made my Australian TV debut joining Jayne and Clint on the 9 News Weekend Today show to talk about endometriosis and my ongoing research at Hudson Institute of Medical Research into new treatment options for sufferers. youtube.com/watch?v=iqfIIl…

Proud to be a part of this incredible team developing novel ways to diagnose and treat endo. We are working hard to know why endo occurs in the first place and how we can treat endo associated infertility 🔬💛 Hudson Institute of Medical Research The Ritchie Centre Monash University School of Clinical Sciences WinRS Caroline Gargett

Hot off the press! Insight into the distinct regulation of IFN epsilon, the epithelial hero. Congrats Ka Yee Fung Paul Hertzog & team!